As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

On a recent weekend afternoon, at a Chinese comedy show in northern Virginia, the host asked the audience, “What food do you ...

Apache Spark creator and Databricks CTO Matei Zaharia wins the 2026 ACM Prize in Computing and argues that AGI has already ...

The next year or so looks to turn the dial up on global warmth even more, as some forecasts predict a brewing El Niño will ...

Unprecedented improvements in arm span observed with TransCon CNP and TransCon hGH combination therapy, a measure highly meaningful to the ...

The Artemis II astronauts are chatting it up with their friends aboard the International Space Station. Still aglow from ...

Five abstracts accepted including Late-breaking Science oral and poster presentations of Phase 3 X-TOLE2 study results for azetukalner in focal ...

San Jose launched the GovAI Coalition in 2023, not long after the introduction of ChatGPT 3, as a way for government agencies ...

John Steinbach was shocked to receive a $281 electricity bill in January 2026—a huge spike from the roughly $100 he’d paid the previous month. “It’s just so far beyond any bill that I’ve ever had,” he ...

Scientists placed 200,000 living human brain cells on a microchip and taught it how to play a doomsday video game — and are now using the dystopian tech to power AI data centers. Australian biotech ...

"This is a challenge unlike any we have encountered thus far in this new era of commercial space." When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works ...

President Donald Trump has spoken favorably of the industry, splitting the Republican Party. Emily L. Mahoney is the energy reporter. Reach her at emahoney@tampabay.com. Anyone can view a sampling of ...